Your browser doesn't support javascript.
loading
Pharmacoepidemiology studies: what levels of evidence and how can they be reached?
Lapeyre-Mestre, Maryse; Sapède, Claudine; Moore, Nicholas; Bilbault, Pascal; Blin, Patrick; Chopy, Damien; Evans, David; Gueyffier, François; Lacoin, Laure; Malbezin, Muriel; Micallef, Joëlle; Morlet-Vigier, Dana; Muller, Sophie; Oger, Emmanuel; Plétan, Yannick; Pons, Gérard; Verpillat, Patrice; Vigneau, Caroline.
Affiliation
  • Lapeyre-Mestre M; Service de Pharmacologie médicale et clinique, Université de Toulouse, INSERM 1027, Toulouse, France.
Therapie ; 68(4): 241-52, 2013.
Article in En, Fr | MEDLINE | ID: mdl-23981262
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacoepidemiology / Evidence-Based Practice Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En / Fr Journal: Therapie Year: 2013 Document type: Article Affiliation country: France Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacoepidemiology / Evidence-Based Practice Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En / Fr Journal: Therapie Year: 2013 Document type: Article Affiliation country: France Country of publication: France